Related Experiment Video
Updated: Sep 4, 2025

An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity
Published on: May 12, 2020
Pharmacological Effects of Caffeic Acid and Its Derivatives in Cancer: New Targeted Compounds for the Mitochondria
Haydeé Bastidas1, Gabriel Araya-Valdés1, Gonzalo Cortés1
1Clinical and Molecular Pharmacology Program, Institute of Biomedical Sciences (ICBM), Faculty of Medicine, Universidad de Chile, Santiago, Chile.
Abstract:
Cancer is a complex pathology of great heterogeneity and difficulty that makes the constant search for new therapies necessary. A major advance on the subject has been made by focusing on the development of new drugs aimed to alter the metabolism of cancer cells, by generating a disruption of mitochondrial function. For this purpose, several new compounds with specific mitochondrial action have been tested, leading successfully to cell death. Recently, attention has centered on a group of natural compounds present in plants named polyphenols, among which is caffeic acid, a polyphenol that has proven to be a powerful antitumoral agent and a prominent compound for studies focused on the development of new therapies against cancer.In this review, we revised the antitumoral capacity and mechanisms of action of caffeic acid and its derivatives, with special emphasis in a new class of caffeic acid derivatives that target mitochondria by chemical binding to the lipophilic cation triphenylphosphonium.
Insights
Caffeic acid, a plant-derived polyphenol, shows potent anticancer effects by disrupting cancer cell metabolism and mitochondrial function. New derivatives targeting mitochondria offer promising therapeutic strategies for cancer treatment.
Area of Science:
- Oncology
- Mitochondrial Biology
- Natural Products Chemistry
Background:
- Cancer's complexity necessitates novel therapeutic approaches, particularly those targeting cancer cell metabolism.
- Mitochondrial dysfunction is a key strategy for inducing cancer cell death.
- Polyphenols, like caffeic acid, are natural compounds with demonstrated antitumoral properties.
Approach:
- This review examines the antitumoral capacity and mechanisms of action of caffeic acid and its derivatives.
- Focus is placed on novel caffeic acid derivatives designed to target mitochondria.
- These derivatives utilize chemical binding to lipophilic cations, such as triphenylphosphonium, for mitochondrial localization.
Key Points:
- Caffeic acid exhibits significant antitumoral activity through various mechanisms.
- Mitochondria are critical targets for cancer therapy, and disrupting their function leads to cancer cell death.
- Novel caffeic acid derivatives are being developed to specifically target and disrupt mitochondrial function in cancer cells.
Conclusions:
- Caffeic acid and its derivatives represent a promising class of compounds for cancer therapy.
- Targeting mitochondrial function is an effective strategy for developing new anticancer drugs.
- Further research into caffeic acid derivatives could lead to innovative cancer treatments.
More Related Videos
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
10:26Assessment of Mitochondrial Health in Cancer-Associated Fibroblasts Isolated from 3D Multicellular Lung Tumor Spheroids
Published on: October 21, 2022
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Inhibition of Cdk Activity
Drugs that Stabilize Microtubules
Drugs that Destabilize Microtubules
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...